Differences in DNA Repair Capacity, Cell Death and Transcriptional Response after Irradiation between a Radiosensitive and a Radioresistant Cell Line

Normal tissue toxicity after radiotherapy shows variability between patients, indicating inter-individual differences in radiosensitivity. Genetic variation probably contributes to these differences. The aim of the present study was to determine if two cell lines, one radiosensitive (RS) and another radioresistant (RR), showed differences in DNA repair capacity, cell viability, cell cycle progression and, in turn, if this response could be characterised by a differential gene expression profile at different post-irradiation times. After irradiation, the RS cell line showed a slower rate of γ-H2AX foci disappearance, a higher frequency of incomplete chromosomal aberrations, a reduced cell viability and a longer disturbance of the cell cycle when compared to the RR cell line. Moreover, a greater and prolonged transcriptional response after irradiation was induced in the RS cell line. Functional analysis showed that 24 h after irradiation genes involved in “DNA damage response”, “direct p53 effectors” and apoptosis were still differentially up-regulated in the RS cell line but not in the RR cell line. The two cell lines showed different response to IR and can be distinguished with cell-based assays and differential gene expression analysis. The results emphasise the importance to identify biomarkers of radiosensitivity for tailoring individualized radiotherapy protocols.

[1]  Dennis B. Troup,et al.  NCBI GEO: archive for functional genomics data sets—10 years on , 2010, Nucleic Acids Res..

[2]  J Nyman,et al.  Prognostic factors for acute and late skin reactions in radiotherapy patients. , 1996, International Journal of Radiation Oncology, Biology, Physics.

[3]  K. Ory,et al.  Deregulated Pathways in a Human Lymphoblastoid Cell Line after Low Doses of Gamma Irradiation , 2006 .

[4]  L. Marro,et al.  Chromosome damage and cell proliferation rates in in vitro irradiated whole blood as markers of late radiation toxicity after radiation therapy to the prostate. , 2013, International journal of radiation oncology, biology, physics.

[5]  Stephen J Kron,et al.  Histone H2AX Phosphorylation as a Predictor of Radiosensitivity and Target for Radiotherapy* , 2004, Journal of Biological Chemistry.

[6]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[7]  John N Weinstein,et al.  Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. , 2008, Cancer research.

[8]  D. Bellows,et al.  Viral versus cellular BCL-2 proteins , 2003, Cell Death and Differentiation.

[9]  C. Alonso,et al.  Mitotic delay in lymphocytes from BRCA1 heterozygotes unable to reduce the radiation-induced chromosomal damage. , 2008, DNA repair.

[10]  J. Overgaard,et al.  Does variability in normal tissue reactions after radiotherapy have a genetic basis--where and how to look for it? , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  S. Roberts,et al.  Lymphocyte radiosensitivity is a significant prognostic factor for morbidity in carcinoma of the cervix. , 2001, International journal of radiation oncology, biology, physics.

[12]  A. Ziegler,et al.  Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[13]  Kai Rothkamm,et al.  Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. B. Grace,et al.  Human In vivo Radiation-Induced Biomarkers , 2004, Cancer Research.

[15]  Fatih Ozsolak,et al.  RNA sequencing: advances, challenges and opportunities , 2011, Nature Reviews Genetics.

[16]  J. Hain,et al.  Increased G2 chromosomal radiosensitivity in cancer patients: the role of cdk1/cyclin-B activity level in the mechanisms involved. , 2000, International journal of radiation biology.

[17]  M. Löbrich,et al.  DNA Double-Strand Break Repair of Blood Lymphocytes and Normal Tissues Analysed in a Preclinical Mouse Model: Implications for Radiosensitivity Testing , 2008, Clinical Cancer Research.

[18]  Jing Chen,et al.  ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..

[19]  Christophe Badie,et al.  Gene expression following ionising radiation: Identification of biomarkers for dose estimation and prediction of individual response , 2011, International journal of radiation biology.

[20]  A. Kiltie,et al.  Biomarkers of Tumour Radiosensitivity and Predicting Benefit from Radiotherapy. , 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

[21]  J. Barquinero,et al.  Characterization of gene expression profiles at low and very low doses of ionizing radiation. , 2013, DNA repair.

[22]  W. Morgan,et al.  Gene expression profiling after irradiation: Clues to understanding acute and persistent responses? , 2004, Cancer and Metastasis Reviews.

[23]  P. Olive,et al.  Phosphorylation of histone H2AX as a measure of radiosensitivity. , 2004, International journal of radiation oncology, biology, physics.

[24]  A. Friedl,et al.  The inter-individual variability outperforms the intra-individual variability of differentially expressed proteins prior and post irradiation in lymphoblastoid cell lines , 2014, Archives of physiology and biochemistry.

[25]  J. Alsner,et al.  Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  P. Rodríguez,et al.  Cells bearing chromosome aberrations lacking one telomere are selectively blocked at the G2/M checkpoint. , 2009, Mutation research.

[27]  E. Dikomey,et al.  Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  A. Dunning,et al.  Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity. , 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

[29]  S. Roberts,et al.  Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. , 1999, International journal of radiation biology.

[30]  M. Southey,et al.  Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients. , 2000, International journal of radiation oncology, biology, physics.

[31]  William F. Blakely,et al.  DNA Repair and Cell Cycle Biomarkers of Radiation Exposure and Inflammation Stress in Human Blood , 2012, PloS one.

[32]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[33]  T. Streichert,et al.  Lymphoblastoid cell lines differing in p53 status show clear differences in basal gene expression with minor changes after irradiation. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  J. Hendry,et al.  Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[35]  Davis J. McCarthy,et al.  Count-based differential expression analysis of RNA sequencing data using R and Bioconductor , 2013, Nature Protocols.

[36]  M. Morley,et al.  Genetic variation in radiation-induced cell death. , 2012, Genome research.

[37]  Chunrong Li,et al.  Identification of differentially expressed genes in human lymphoblastoid cells exposed to irradiation and suppression of radiation-induced apoptosis with antisense oligonucleotides against caspase-4. , 2007, Oligonucleotides.

[38]  H. Blattmann,et al.  High levels of delayed radiation-induced apoptosis observed in lymphoblastoid cell lines from ataxia-telangiectasia patients. , 2001, International journal of radiation oncology, biology, physics.

[39]  V. Cheung,et al.  Transcriptional response of lymphoblastoid cells to ionizing radiation. , 2003, Genome research.

[40]  H. Eich,et al.  Evaluation of Different Biomarkers to Predict Individual Radiosensitivity in an Inter-Laboratory Comparison–Lessons for Future Studies , 2012, PloS one.

[41]  T. Illig,et al.  The WST survival assay: an easy and reliable method to screen radiation-sensitive individuals. , 2011, Radiation protection dosimetry.

[42]  Axel Benner,et al.  A radiation-induced gene expression signature as a tool to predict acute radiotherapy-induced adverse side effects. , 2011, Cancer letters.

[43]  R. Shamir,et al.  Transcriptional modulation induced by ionizing radiation: p53 remains a central player , 2011, Molecular oncology.

[44]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[45]  P. Jeggo,et al.  Cellular radiosensitivity: How much better do we understand it? , 2009, International journal of radiation biology.

[46]  C. Lim,et al.  The effects of NBS1 knockdown by small interfering RNA on the ionizing radiation-induced apoptosis in human lymphoblastoid cells with different p53 status. , 2007, Toxicology letters.

[47]  C. Parris,et al.  Prolonged expression of the γ-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment , 2011, International journal of cancer.

[48]  N. Willich,et al.  Evidence for predictive validity of blood assays to evaluate individual radiosensitivity. , 2006, International journal of radiation oncology, biology, physics.

[49]  M. E. Perry.  Mdm2 in the response to radiation. , 2004, Molecular cancer research : MCR.

[50]  L. Zhao,et al.  Identification of Radiation-Induced Expression Changes in Nonimmortalized Human T Cells , 2010, Radiation research.

[51]  J. Yarnold,et al.  Residual DNA and chromosomal damage in ex vivo irradiated blood lymphocytes correlated with late normal tissue response to breast radiotherapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[52]  Matthew D. Young,et al.  Gene ontology analysis for RNA-seq: accounting for selection bias , 2010, Genome Biology.

[53]  P. Jeggo,et al.  Irradiation induced foci (IRIF) as a biomarker for radiosensitivity. , 2012, Mutation research.

[54]  H. Forrester,et al.  Alternative Transcript Initiation and Splicing as a Response to DNA Damage , 2011, PloS one.

[55]  T. Illig,et al.  Genetic factors in individual radiation sensitivity. , 2014, DNA repair.

[56]  Paul Theodor Pyl,et al.  HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[57]  K. Ory,et al.  DNA damage-related RNA expression to assess individual sensitivity to ionizing radiation. , 2001, Carcinogenesis.

[58]  K. Rothkamm,et al.  Biomarkers of radiation exposure: can they predict normal tissue radiosensitivity? , 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

[59]  J. Peacock,et al.  Describing patients' normal tissue reactions: Concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity , 1998, International journal of cancer.

[60]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[61]  G. Terzoudi,et al.  A standardized G2-assay for the prediction of individual radiosensitivity. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[62]  P. Jeggo,et al.  The impact of a negligent G2/M checkpoint on genomic instability and cancer induction , 2007, Nature Reviews Cancer.

[63]  Namshin Kim,et al.  Investigation of Radiation-induced Transcriptome Profile of Radioresistant Non-small Cell Lung Cancer A549 Cells Using RNA-seq , 2013, PloS one.

[64]  A. Friedl,et al.  Radiation-induced alterations of histone post-translational modification levels in lymphoblastoid cell lines , 2014, Radiation oncology.

[65]  A. Taylor,et al.  Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity , 1975, Nature.

[66]  P. Moll,et al.  QuantSeq 3[prime] mRNA sequencing for RNA quantification , 2014 .

[67]  L. Liang,et al.  Mapping complex disease traits with global gene expression , 2009, Nature Reviews Genetics.

[68]  J. Barquinero,et al.  Comparison of methods to quantify histone H2AX phosphorylation and its usefulness for prediction of radiosensitivity , 2015, International journal of radiation biology.

[69]  H. Forrester,et al.  Identification of a radiation sensitivity gene expression profile in primary fibroblasts derived from patients who developed radiotherapy-induced fibrosis. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[70]  Alison M. Dunning,et al.  Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype , 2009, Nature Reviews Cancer.

[71]  J. Dickinson,et al.  RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization , 2014, BMC Cancer.

[72]  Penny A Jeggo,et al.  Understanding the limitations of radiation-induced cell cycle checkpoints , 2011, Critical reviews in biochemistry and molecular biology.